NDC 68382-0041 - Promethazine hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68382-0041
- Manufacturer
- State of Florida DOH Central Pharmacy
- Effective date
- 2010-06-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Promethazine hydrochloride - State of Florida DOH Central Pharmacy | State of Florida DOH Central Pharmacy | 2010-06-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PROMETHAZINE HYDROCHLORIDE | ACTIVE INGREDIENT | R61ZEH7I1I | PROMETHAZINE HYDROCHLORIDE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| PROMETHAZINE | ACTIVE MOIETY | FF28EJQ494 | PROMETHAZINE HYDROCHLORIDE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | PROMETHAZINE HYDROCHLORIDE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | PROMETHAZINE HYDROCHLORIDE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | PROMETHAZINE HYDROCHLORIDE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | PROMETHAZINE HYDROCHLORIDE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | PROMETHAZINE HYDROCHLORIDE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nocturnal Enuresis Drops 2011 | NOCTURNAL ENURESIS DROPS | Professional Complementary Health Formulas | 9cd29086-c9eb-4db1-a219-2a8bae3663d8 | 2026-01-08 | Warnings | L11K75P92J |
| Ledum Combination 9257 | LEDUM COMBINATION | Professional Complementary Health Formulas | 38b89b32-4915-487d-8b2d-250123487b15 | 2026-01-08 | Warnings | L11K75P92J |
| RET Lung 7003 | RET LUNG | Professional Complementary Health Formulas | 2ed03832-f226-4b3c-9ee6-5352f8d79fdb | 2026-01-08 | Warnings | L11K75P92J |
| Myosotis Combination 9234 | MYOSOTIS COMBINATION | Professional Complementary Health Formulas | 8cc292dc-b959-4d81-8277-03044992fccb | 2026-01-08 | Warnings | L11K75P92J |
| Anti-Scar Drops 2084 | ANTI-SCAR DROPS | Professional Complementary Health Formulas | ad0e9159-ed68-48aa-a7d1-7ff5c32ec304 | 2026-01-08 | Warnings | L11K75P92J |
| Fifth Chakra (Throat) 7305 | FIFTH CHAKRA (THROAT) | Professional Complementary Health Formulas | b731f708-10a8-451f-8550-1e7302102b96 | 2026-01-08 | Warnings | L11K75P92J |
| Dementia Drops 2117 | DEMENTIA DROPS | Professional Complementary Health Formulas | 83aec02b-bc62-49a2-ba35-4ac94f9bfc6e | 2026-01-08 | Warnings | L11K75P92J |
| Promethazine and Phenylephrine HCl, and Codeine Phosphate | PROMETHAZINE, PHENYLEPHRINE, CODEINE | Amneal Pharmaceuticals LLC | 5f23b254-872b-4e88-91be-710c3ea7687b | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| Promethazine Hydrochloride | PROMETHAZINE HYDROCHLORIDE | Northwind Health Company, LLC | f6ca1097-1c75-c682-e053-6294a90a2bd6 | 2026-01-01 | Warnings, Adverse reactions | 992447 R61ZEH7I1I |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | Northwind Health Company, LLC | d9cb1a44-d646-d9e9-e053-2995a90a24ff | 2026-01-01 | Warnings, Adverse reactions | 992447 R61ZEH7I1I |
| Promethazine Hydrochloride | PROMETHAZINE HYDROCHLORIDE | Northwind Health Company, LLC | 075f052e-7f38-7f75-e063-6394a90a512b | 2026-01-01 | Warnings, Adverse reactions | 992447 R61ZEH7I1I |
| Promethazine Hydrochloride | PROMETHAZINE HYDROCHLORIDE | Northwind Health Company, LLC | ba4ec2d8-1da4-473b-9ef8-57051cb2c0f7 | 2025-12-26 | Warnings, Adverse reactions | 992447 R61ZEH7I1I |
| Promethazine Hydrochloride | PROMETHAZINE HYDROCHLORIDE | Amneal Pharmaceuticals of New York LLC | 0b5734b8-6a52-44ff-ac29-9a91a4335394 | 2025-12-20 | Warnings, Adverse reactions | 992447 R61ZEH7I1I |
| Promethazine Hydrochloride | PROMETHAZINE HYDROCHLORIDE | ProPharma Distribution | 38673af1-112e-9ddd-e063-6294a90af465 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| Promethazine Hydrochloride and Codeine Phosphate | PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE | Cosette Pharmaceuticals, Inc. | 3b02cda4-9b24-79c9-e063-6294a90af5b9 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| Promethazine Hydrochloride and Codeine Phosphate | PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE | Cranbury Pharmaceuticals, LLC | 785c605e-1907-4fac-8b69-d504a2076f8e | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| Promethazine Hydrochloride and Dextromethorphan Hydrobromide | PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | Cranbury Pharmaceuticals, LLC | a8b57027-a4b8-4149-93e8-aa3e7a6d6dc3 | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| promethazine hydrochloride | PROMETHAZINE HYDROCHLORIDE | Cranbury Pharmaceuticals, LLC | d32ea9db-11d4-400d-b7ef-dd0ec01b796d | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | ProPharma Distribution | 45b09a50-dab2-e83d-e063-6394a90aa813 | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| promethazine hydrochloride | PROMETHAZINE HYDROCHLORIDE | ATLANTIC BIOLOGICALS CORP | 69934bbb-922c-4752-b253-f2f07340de8d | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.